And now the fun begins. Has the old girl got life in it? Will a little shock treatment get the Share Price Beating? Who knows what's ahead- lets hope for some great news for all us holders!
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress